Chamomile (Matricaria chamomilla)
Chamomile (Matricaria chamomilla) is a daisy family plant whose dried flower heads make one of the most popular single ingredient herbal teas. The flowers contain flavonoids, mainly apigenin and its glucosides, and an essential oil rich in alpha bisabolol and chamazulene. Much of its reputation comes from traditional use rather than clinical testing. In adults diagnosed with an anxiety disorder, an 8 week placebo-controlled extract trial found a greater drop in anxiety ratings than placebo, and a longer trial in people who had already responded missed its main relapse goal while symptom scores stayed lower than on placebo. Sleep trials found better self-rated sleep quality but not longer sleep, and a placebo-controlled trial in chronic insomnia found no difference. Chamomile tea can reduce iron absorption from a meal, and people allergic to daisy family plants can react to it.
Benefits
Anxiety rating scores in placebo-controlled extract trials
In an 8 week double blind trial of 57 adults diagnosed with generalized anxiety disorder, chamomile extract lowered Hamilton Anxiety Rating Scale scores more than placebo (P = 0.047). In a longer trial of people who had already responded, staying on chamomile did not significantly reduce relapse (P = 0.16), though symptom scores rose less than on placebo. Neither trial tested everyday stress in healthy people.
Traditional use as a bedtime tea
Chamomile tea is a traditional evening drink, and apigenin, one of its flavonoids, binds central benzodiazepine receptors in laboratory work and reduced anxiety-like behavior in mice. Tradition and animal work are not human trials and do not show that chamomile works like a sleep medication. The controlled human results are summarized in the sleep quality benefit on this page.
Traditional use for digestive comfort
Chamomile has long been used to settle the stomach, and animal studies summarized in a review report antispasmodic and anti-inflammatory effects. None of the studies cited on this page tested digestion in people, so this rests on tradition and animal work only, and chamomile is not a treatment for digestive diseases.
Anti-inflammatory activity in animal studies
The flowers contain flavonoids and an essential oil rich in alpha bisabolol and chamazulene, and animal model studies summarized in a review report anti-inflammatory activity. No human trial cited on this page measured inflammatory markers, and studies of chamomile applied to the skin say nothing about drinking it or taking it in a capsule.
HbA1c and insulin readings in an 8 week tea trial
In a single blind trial, 64 adults aged 30 to 60 with type 2 diabetes drank chamomile tea (3 g in 150 mL) three times a day after meals or followed a water regimen for 8 weeks. HbA1c (p = 0.03), insulin and insulin resistance fell more with tea, as did total cholesterol and triglycerides. The control was plain water rather than a placebo drink, and the trial does not show effects in people without diabetes.
Self-rated sleep quality on questionnaires
In a single blind trial, 60 adults aged 60 and over took 200 mg chamomile extract or flour capsules twice daily for 28 days, and self-rated sleep quality (PSQI) ended better with chamomile. A pooled analysis of five trials found a PSQI drop of about 1.9 points with very high heterogeneity and no gain in sleep duration or efficiency. A placebo-controlled trial in chronic insomnia found no sleep diary difference.
Mechanism of action
Apigenin binding at central benzodiazepine receptors
Apigenin, a flavonoid isolated from chamomile flowers, competed with a benzodiazepine for binding to central benzodiazepine receptors in laboratory tests and reduced anxiety-like behavior in mice, with mild sedation only at a tenfold higher dose. How much apigenin from tea or a capsule reaches the human brain is not established, and this work does not show that chamomile acts like a prescription sedative.
Anti-inflammatory and antispasmodic activity in animal studies
A review of chamomile research reports anti-inflammatory and antispasmodic effects in animal models and antiplatelet activity in test tube work, from flowers rich in apigenin, alpha bisabolol and chamazulene. These findings come from cell and animal models and have not been shown to produce measured effects on inflammation or digestion in the human research cited on this page.
Clinical trials
Two-phase relapse prevention trial in adults with moderate to severe generalized anxiety disorder (NCT01072344), funded by NIH. All 179 took open-label chamomile extract 1,500 mg a day (500 mg three times daily) for 12 weeks; the 93 responders were then randomized to continue chamomile (46) or switch to placebo (47) for 26 weeks. Primary outcome: time to relapse. (Mao et al. 2016, Phytomedicine)
179 adult outpatients entered the open-label phase; only the 93 who responded went on to the randomized phase.
The primary outcome was not met: relapse occurred in 7 of 46 on chamomile versus 12 of 47 on placebo (hazard ratio 0.52, 95% CI 0.20 to 1.33, P = 0.16). Secondary results favored chamomile: GAD-7 scores rose less than on placebo (P = 0.0032), and body weight and mean arterial blood pressure fell more. HAM-A and Beck inventory scores showed the same trend without reaching significance. Possibly or probably related adverse events were similar (17.4% versus 19.1%) and all were mild.
Single blind randomized trial in adults aged 30 to 60 with type 2 diabetes: chamomile tea (3 g in 150 mL hot water) three times a day immediately after meals versus a water regimen for 8 weeks. (Rafraf et al. 2015, J Endocrinol Invest)
64 adults aged 30 to 60 with type 2 diabetes (32 per group).
Compared with water, chamomile tea lowered HbA1c (p = 0.03), serum insulin and HOMA-IR insulin resistance (both p < 0.001), total cholesterol (p = 0.001), triglycerides (p < 0.001) and LDL cholesterol (p = 0.05); HDL cholesterol did not change in either group. The control was plain water rather than a placebo drink, and the trial does not show effects in people without diabetes.
Randomized, double blind, placebo-controlled trial of German chamomile extract standardized to 1.2% apigenin, 220 mg capsules started at 1 a day and raised to as many as 5 a day, for 8 weeks in outpatients with generalized anxiety disorder; NIH funded. (Amsterdam et al. 2009, J Clin Psychopharmacol)
57 randomized adult outpatients with mild to moderate anxiety (28 chamomile, 29 placebo).
Total HAM-A anxiety scores fell more on chamomile than on placebo (P = 0.047). Secondary outcomes moved in the same direction, but the trial was not powered to detect them. One patient in each group stopped because of adverse events, and adverse event counts did not differ (P = 0.417).
Single blind randomized trial: chamomile extract 200 mg capsules twice daily versus 200 mg wheat flour capsules for 28 days in a day care nursing home in Karaj, Iran; outcome was the Pittsburgh Sleep Quality Index. (Adib-Hajbaghery et al. 2017, Complement Ther Med)
60 adults aged 60 and over (mean age about 70) with low baseline sleep quality.
Baseline sleep quality was low in both groups and did not differ (P = 0.639), although one component, habitual sleep efficiency, differed at baseline. After 28 days, PSQI sleep quality was significantly better with chamomile than with flour capsules (P < 0.05). Sleep was self-rated and the trial was single blind.
Randomized, double blind, placebo-controlled pilot in adults with DSM-IV chronic primary insomnia for at least 6 months: 270 mg chamomile extract twice daily for 28 days; primary outcomes were sleep diary measures. Funded by a University of Michigan seed grant and an NIH clinical research award; the extract maker gave no financial support. (Zick et al. 2011, BMC Complement Altern Med)
34 adults aged 18 to 65.
None of the diary measures (total time, efficiency, latency, wake time after onset, quality and number of awakenings) differed significantly from placebo. Effect sizes for latency, night awakenings and fatigue were moderate in favor of chamomile and total time was moderate in favor of placebo, none significant. Daytime functioning showed a nonsignificant advantage, and adverse events did not differ.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Chamomile (Matricaria chamomilla)
What is the recommended dosage of Chamomile?
There is no established recommended dose. Anxiety trials used standardized extract at up to 1,100 mg a day for 8 weeks and 1,500 mg a day (500 mg three times daily) in a longer trial, and sleep trials used 200 mg or 270 mg twice daily. Drinking one to three cups of tea, often in the evening, reflects traditional use rather than a tested dose.
What is Chamomile used for?
Chamomile is traditionally used for relaxation, sleep and digestive comfort. The research is narrower than the tradition: it has mainly been tested as a standardized extract in adults diagnosed with generalized anxiety disorder and in small sleep trials, not in healthy people dealing with everyday stress, and no study cited here tested digestion.
Does chamomile help you sleep?
Possibly a little. In a trial in adults aged 60 and over, 200 mg of chamomile extract twice daily for 28 days improved self-rated sleep quality more than flour capsules, and a pooled analysis of five trials found a small improvement on the same questionnaire. Sleep length and sleep efficiency did not improve, and a placebo-controlled trial in chronic insomnia found no difference, so treat it as a gentle evening routine rather than a sleep medication.
Is Chamomile safe, and does it have side effects?
Side effects reported in clinical trials were mostly mild, most often stomach upset and drowsiness. People allergic to daisy family plants such as ragweed, chrysanthemums and marigolds can react, and rare anaphylaxis has been reported. Chamomile tea with a meal can reduce iron absorption, and people taking warfarin, sedatives or diabetes medication should check with a clinician first. Safety in pregnancy and breastfeeding has not been established.
Can chamomile tea affect iron absorption?
Yes. In an adult study using labeled iron, chamomile tea served with a bread meal reduced nonheme iron absorption by 47% compared with water, and other herb teas, black tea, coffee and cocoa had similar or larger effects. If your iron is low, consider drinking chamomile between meals rather than with them.
What is Chamomile?
Chamomile (Matricaria chamomilla) is a daisy family plant whose dried flower heads make one of the most popular single ingredient herbal teas. The flowers contain flavonoids, mainly apigenin and its glucosides, and an essential oil rich in alpha bisabolol and chamazulene.
Does Chamomile interact with any medications?
Possible interactions include: Warfarin: a 70 year old woman taking warfarin was hospitalized with internal bleeding after using chamomile tea and lotion (one case report), while a 7 day crossover trial in 12 healthy volunteers not taking warfarin found no change in clotting tests; ask your clinician before re… If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Chamomile?
NutraSmarts rates the evidence for Chamomile as Limited (2 out of 5). It is backed by 5 study summaries and 13 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(13 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine. 2016;23(14):1735-1742. doi: 10.1016/j.phymed.2016.10.012.PubMedUsed to support: Two-phase NIH-funded trial in adults with moderate to severe generalized anxiety disorder: 179 took open-label extract 1,500 mg a day for 12 weeks, and 93 responders were randomized to continue chamomile or switch to placebo for 26 weeks. Time to relapse, the primary outcome, did not differ significantly (hazard ratio 0.52, 95% CI 0.20 to 1.33, P = 0.16); GAD-7 symptoms rose less on chamomile (P = 0.0032), and adverse events were similar and mild.
- A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29(4):378-82. doi: 10.1097/JCP.0b013e3181ac935c.PubMedUsed to support: Randomized, double blind, placebo-controlled 8 week trial in 57 adults with mild to moderate generalized anxiety disorder using extract standardized to 1.2% apigenin (220 mg capsules, 1 to 5 a day). Total HAM-A scores fell more on chamomile than on placebo (P = 0.047); secondary outcomes moved the same way but the study was not powered for them. NIH funded.
- Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes. J Endocrinol Invest. 2015;38(2):163-70. doi: 10.1007/s40618-014-0170-x.PubMedUsed to support: Single blind randomized trial in 64 adults aged 30 to 60 with type 2 diabetes: chamomile tea (3 g in 150 mL hot water) three times daily after meals versus a water regimen for 8 weeks. HbA1c (p = 0.03), insulin and HOMA-IR (both p < 0.001), total cholesterol, triglycerides and LDL cholesterol fell more than with water; HDL did not change. The control was plain water rather than a placebo drink.
- Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials. Complement Ther Med. 2024;84:103071. doi: 10.1016/j.ctim.2024.103071.PubMedUsed to support: Systematic review of 10 chamomile trials (772 participants) in healthy or diseased adults. Pooled PSQI score fell (WMD -1.88, 95% CI -3.46 to -0.31; 5 trials) with very high heterogeneity (I2 88.4%). Sleep onset latency improved in three of four studies and night awakenings in two of three; sleep duration did not improve, sleep efficiency did not change in two studies and worsened in one, and daytime functioning did not change. Only one included study checked blinding and product potency.
- The effects of chamomile extract on sleep quality among elderly people: A clinical trial. Complement Ther Med. 2017;35:109-114. doi: 10.1016/j.ctim.2017.09.010.PubMedUsed to support: Single blind randomized trial in 60 nursing home day care adults aged 60 and over: chamomile extract 200 mg capsules twice daily for 28 days versus wheat flour capsules. PSQI sleep quality was significantly better than control after the intervention (P < 0.05). Small, single blind and self-rated.
- Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011;11:78. doi: 10.1186/1472-6882-11-78.PubMedUsed to support: Double blind placebo-controlled pilot in 34 adults with chronic primary insomnia, funded by a University of Michigan seed grant and an NIH clinical research award (the extract maker gave no support): 270 mg chamomile twice daily for 28 days produced no significant differences from placebo on any sleep diary measure (total sleep time, efficiency, latency, wake after sleep onset, quality, awakenings); adverse events did not differ.
- Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr. 1999;81(4):289-95. doi: 10.1017/s0007114599000537.PubMedUsed to support: Radio-iron absorption study in adults: compared with water, chamomile tea served with a bread meal reduced nonheme iron absorption by 47%; every polyphenol-containing beverage tested (black tea, coffee, cocoa and several herb teas) inhibited iron absorption.
- Chamomile: A systematic review of adverse events. Complement Ther Med. 2025;91:103192. doi: 10.1016/j.ctim.2025.103192.PubMedUsed to support: Systematic review of 72 trials and 11 case reports: among 2,896 trial participants given chamomile, 65 adverse events were reported in 10 trials, most often self-limiting digestive complaints and drowsiness. No allergic events occurred in trials, but 6 of 11 case reports described allergic reactions, including anaphylaxis in three patients. Data on pregnancy and breastfeeding were insufficient, and adverse event reporting in trials was incomplete.
- A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006;20(7):519-30. doi: 10.1002/ptr.1900.PubMedUsed to support: Review: chamomile flowers contain flavonoids (mainly apigenin and its glucosides) and an essential oil rich in alpha-bisabolol and chamazulene. Animal studies show anti-inflammatory, antispasmodic and anxiolytic effects and test tube work shows antiplatelet activity; human studies are limited, and allergic reactions have been reported in people allergic to other daisy (Asteraceae) family plants.
- Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995;61(3):213-6. doi: 10.1055/s-2006-958058.PubMedUsed to support: Laboratory and mouse study: apigenin isolated from chamomile flowers bound central benzodiazepine receptors (Ki 4 microM) without affecting muscimol binding at GABA-A receptors, reduced anxiety-like behavior in mice, and caused mild sedation only at a tenfold higher dose. Not a human study.
- Warfarin interaction with Matricaria chamomilla. CMAJ. 2006;174(9):1281-2. doi: 10.1503/cmaj.051191.PubMedUsed to support: Case report: a 70 year old woman taking warfarin was hospitalized with multiple internal hemorrhages after using chamomile tea and body lotion. A single case report cannot establish cause.
- Effect of chamomile intake on blood coagulation tests in healthy volunteers: a randomized, placebo-controlled, crossover trial. Perioper Med (Lond). 2023;12(1):51. doi: 10.1186/s13741-023-00339-7.PubMedUsed to support: Randomized, placebo-controlled crossover trial in 12 healthy volunteers not taking warfarin: 7 days of chamomile tea (9 tea bags a day) or chamomile extract capsules did not change prothrombin time, INR, aPTT or other clotting tests compared with placebo capsules.
- Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sci. 2006;78(8):856-61. doi: 10.1016/j.lfs.2005.05.095.PubMedUsed to support: Test tube study with recombinant human enzymes: chamomile essential oil inhibited CYP1A2 most, and its constituents chamazulene and cis- and trans-spiroether inhibited CYP1A2 and CYP3A4; chamazulene and alpha-bisabolol inhibited CYP2D6. In vitro only; human relevance is not established.